Additionally, Brdu assay, transwell assay, qRT-PCR, Western blot analysis, and flow cytometry collectively illustrated that HCP5 promoted HCC progression via repressing miR-29b-3p. This evidence concerns the gene HCP5 and hepatocellular carcinoma.